Difficulty: Medium
Average Score: 72%
Practice
A 69-year-old man with a history of squamous cell carcinoma of the larynx underwent treatment with surgical resection and postoperative radiation therapy. He currently has significant xerostomia. Which of the following would be the best course of treatment for this patient?
Correct answer
D
Rationale
The best course of treatment for the 69-year-old man with significant xerostomia following treatment for squamous cell carcinoma of the larynx is option D) Pilocarpine. Pilocarpine is a cholinergic agonist that stimulates saliva production, making it an effective treatment for xerostomia.
Option A) Bethanechol is also a cholinergic agonist, but it is not as effective for xerostomia as pilocarpine. Carbachol (option B) is primarily used in the eye and is not a common treatment for xerostomia. Option C) suggesting oral liquid intake is not a targeted treatment for xerostomia and may not provide adequate relief for the patient's condition.
In the context of pharmacology across the lifespan, understanding the appropriate use of medications like pilocarpine in managing side effects of cancer treatment is crucial. Educating healthcare providers about the mechanism of action and appropriate indications for medications can lead to improved patient outcomes and quality of life. It is essential to consider individual patient characteristics such as age, comorbidities, and treatment history when selecting the most suitable pharmacological interventions.
Option A) Bethanechol is also a cholinergic agonist, but it is not as effective for xerostomia as pilocarpine. Carbachol (option B) is primarily used in the eye and is not a common treatment for xerostomia. Option C) suggesting oral liquid intake is not a targeted treatment for xerostomia and may not provide adequate relief for the patient's condition.
In the context of pharmacology across the lifespan, understanding the appropriate use of medications like pilocarpine in managing side effects of cancer treatment is crucial. Educating healthcare providers about the mechanism of action and appropriate indications for medications can lead to improved patient outcomes and quality of life. It is essential to consider individual patient characteristics such as age, comorbidities, and treatment history when selecting the most suitable pharmacological interventions.